Cargando…

Primary clear cell adenocarcinoma of the lung: a national analysis

BACKGROUND: Primary clear cell adenocarcinoma of the lung (CCAL) is a rare form of lung cancer with poorly understood clinical features. We sought to investigate the clinicopathological characteristics and independent prognostic factors of primary CCAL. METHODS: Overall survival (OS) of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansur, Arian, Saleem, Zain, Potter, Alexandra L., Mathey-Andrews, Camille, Senthil, Priyanka, Yang, Chi-Fu Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482654/
https://www.ncbi.nlm.nih.gov/pubmed/37691684
http://dx.doi.org/10.21037/jtd-23-76
_version_ 1785102218969481216
author Mansur, Arian
Saleem, Zain
Potter, Alexandra L.
Mathey-Andrews, Camille
Senthil, Priyanka
Yang, Chi-Fu Jeffrey
author_facet Mansur, Arian
Saleem, Zain
Potter, Alexandra L.
Mathey-Andrews, Camille
Senthil, Priyanka
Yang, Chi-Fu Jeffrey
author_sort Mansur, Arian
collection PubMed
description BACKGROUND: Primary clear cell adenocarcinoma of the lung (CCAL) is a rare form of lung cancer with poorly understood clinical features. We sought to investigate the clinicopathological characteristics and independent prognostic factors of primary CCAL. METHODS: Overall survival (OS) of patients with CCAL in the National Cancer Database (NCDB) from 2004 to 2017 was compared to lung adenocarcinoma using Kaplan-Meier analysis, multivariable Cox proportional hazards modeling, and propensity score matching. Independent prognostic indicators for patients with CCAL were determined using multivariable Cox proportional hazards analysis. RESULTS: A total of 1,396 CCAL and 462,360 lung adenocarcinoma patients were included in our analysis. When compared to patients diagnosed with lung adenocarcinoma, those diagnosed with CCAL were more likely to be younger, white, reside farther from a hospital, have higher Charlson/Deyo comorbidity condition (CDCC) scores, have private insurance, have T1, N0, M0 status. In unadjusted analysis, patients with CCAL had better survival than those with lung adenocarcinoma, although no significant differences in survival were found between the two groups with multivariable Cox proportional hazards and propensity score-matched analyses. CONCLUSIONS: In this national analysis, we found that the clinicopathological characteristics of CCAL are distinct from those of lung adenocarcinoma, but CCAL is not itself an independent predictor of survival after multivariable adjustment or propensity score-matched analysis.
format Online
Article
Text
id pubmed-10482654
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-104826542023-09-08 Primary clear cell adenocarcinoma of the lung: a national analysis Mansur, Arian Saleem, Zain Potter, Alexandra L. Mathey-Andrews, Camille Senthil, Priyanka Yang, Chi-Fu Jeffrey J Thorac Dis Original Article BACKGROUND: Primary clear cell adenocarcinoma of the lung (CCAL) is a rare form of lung cancer with poorly understood clinical features. We sought to investigate the clinicopathological characteristics and independent prognostic factors of primary CCAL. METHODS: Overall survival (OS) of patients with CCAL in the National Cancer Database (NCDB) from 2004 to 2017 was compared to lung adenocarcinoma using Kaplan-Meier analysis, multivariable Cox proportional hazards modeling, and propensity score matching. Independent prognostic indicators for patients with CCAL were determined using multivariable Cox proportional hazards analysis. RESULTS: A total of 1,396 CCAL and 462,360 lung adenocarcinoma patients were included in our analysis. When compared to patients diagnosed with lung adenocarcinoma, those diagnosed with CCAL were more likely to be younger, white, reside farther from a hospital, have higher Charlson/Deyo comorbidity condition (CDCC) scores, have private insurance, have T1, N0, M0 status. In unadjusted analysis, patients with CCAL had better survival than those with lung adenocarcinoma, although no significant differences in survival were found between the two groups with multivariable Cox proportional hazards and propensity score-matched analyses. CONCLUSIONS: In this national analysis, we found that the clinicopathological characteristics of CCAL are distinct from those of lung adenocarcinoma, but CCAL is not itself an independent predictor of survival after multivariable adjustment or propensity score-matched analysis. AME Publishing Company 2023-08-28 2023-08-31 /pmc/articles/PMC10482654/ /pubmed/37691684 http://dx.doi.org/10.21037/jtd-23-76 Text en 2023 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Mansur, Arian
Saleem, Zain
Potter, Alexandra L.
Mathey-Andrews, Camille
Senthil, Priyanka
Yang, Chi-Fu Jeffrey
Primary clear cell adenocarcinoma of the lung: a national analysis
title Primary clear cell adenocarcinoma of the lung: a national analysis
title_full Primary clear cell adenocarcinoma of the lung: a national analysis
title_fullStr Primary clear cell adenocarcinoma of the lung: a national analysis
title_full_unstemmed Primary clear cell adenocarcinoma of the lung: a national analysis
title_short Primary clear cell adenocarcinoma of the lung: a national analysis
title_sort primary clear cell adenocarcinoma of the lung: a national analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482654/
https://www.ncbi.nlm.nih.gov/pubmed/37691684
http://dx.doi.org/10.21037/jtd-23-76
work_keys_str_mv AT mansurarian primaryclearcelladenocarcinomaofthelunganationalanalysis
AT saleemzain primaryclearcelladenocarcinomaofthelunganationalanalysis
AT potteralexandral primaryclearcelladenocarcinomaofthelunganationalanalysis
AT matheyandrewscamille primaryclearcelladenocarcinomaofthelunganationalanalysis
AT senthilpriyanka primaryclearcelladenocarcinomaofthelunganationalanalysis
AT yangchifujeffrey primaryclearcelladenocarcinomaofthelunganationalanalysis